Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ducts. According to current estimates, between 5 and 16 in every 100,000 people have PSC. The symptoms of PSC ...

portion of the Phase 2 SPRING study evaluating nebokitug as a treatment for patients with primary sclerosing cholangitis (PSC), a chronic liver disease. OLE participants who had been in the ...

Chemomab Therapeutics (CMMB) announced results from the Open Label Extension portion of the Phase 2 SPRING trial assessing nebokitug as a ...

Healthcare providers look to rule out other liver disorders, such as biliary obstruction, hepatitis, primary sclerosing cholangitis (a chronic inflammation of the bile ducts), and liver disease ...

For primary sclerosing cholangitis there are no established immunomodulatory therapies, but medical, endoscopic, and surgical treatments are applicable to this disease. Liver transplantation ...

Mirum Pharmaceuticals, Inc. shows strong growth with a 43% revenue jump and promising pipeline assets. Click here for my ...

Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...

A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.

A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...